At present, bone grafts are the standard treatment to enhance bone healing in many clinical situations. Unfortunately, there are many drawbacks associated with current methods of assisted osteogenesis. Certain bone growth factors called Bone Morphogenetic Proteins (BMPs) have been shown to improve osteoinduction. Therefore, their use as an alternative for bone grafts is compelling. An appropriate delivery vehicle for these growth factors is critical in their effectiveness. This study tests Polylactide-co-Glycolide as a potential carrier.
Worcester Polytechnic Institute
Major Qualifying Project
Access to this report is limited to members of the WPI community. Please contact a project advisor or their department to request access
Restricted-WPI community only
Biology and Biotechnology